Pursuant to the approval granted by the shareholders vide postal ballot on 5th September , 2018, Glaxosmithkline Pharmaceuticals has informed that as authorized by Board the meeting of Managing Director, Whole-time Director and Company Secretary held on 14th September 2018, has approved the allotment of 8,47,03,017 fully paid-up bonus equity shares to the existing shareholders in the ratio of one bonus equity share of face value Re 10 each credited as fully paid up for every one equity shares of face value Re 10 each held on the Record date viz. 13th September 2018. The post issued paid up capital of the Company is now Rs 169,40,60,340.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1528.20 |
Dr. Reddys Lab | 5884.80 |
Cipla | 1404.25 |
Zydus Lifesciences | 999.40 |
Lupin | 1638.40 |
View more.. |